TH257

TH257 : Allosteric inhibitor of LIMK1 and LIMK2

Structure

Information

  • LIMK1
  • LIMK2
  • Allosteric, Type III
  • Allosteric,Type III
  • up to 1 uM

In Vitro Validations

Uniprot ID: P53667
Target Class: Kinase
Target SubClass: TKL
Potency: IC50
Potency Value: 84 nM
Potency Assay: RapidFire MS assay
PDB ID for probe-target interaction (3D structure): --
Target aliases:
LIM domain kinase 1, LIMK, LIMK1, LIMK1_HUMAN, LIM ...

DOI Reference: 10.1021/acs.jmedchem.2c01106

In Cell Validations

In Vivo Data

No in Vivo Validations

Off-Target Selectivity Assesments

Potency assay (off target): TH257 is exquisitely selective and no significant activity against the wider kinome has been observed in the KINOMEscan assay (Dx) at 1 μM (IC50 >> 50 % inhibition)
I have extra information to add

SERP ratings and comments


SERP Ratings

In Cell Rating

(last updated: 25 May 2017 )

SERP Ratings

In Cell Rating

SERP Comments:

Selective allosteric molecule for use in cells to probe the effects of LIMK inhibition.

(last updated: 2 Jun 2017 )

SERP Ratings

In Cell Rating

SERP Comments:

Potent and selective chemical probe for LIMK1/2 kinases. TH-257 appears to bear a minor chemical modification from a previously disclosed 40 nM allosteric inhibitor (butyl replacement for a methyl group). Surpasses many of the SGC set criteria for potency and selectivity, and a very weak binding control compound is included. Would be helpful to provide more off-target profiling e.g. against ion channel, GPCRs etc. as well as cell-based activity data (LIMK substrate(s) are known) and ideally showing on-target effect.

(last updated: 20 Jun 2017 )